Discover Great Companies Discover Great Clients
Popularity  36.1万   |   Followers  936   |   Likes  82   |   Feedback  826 Claim this company

Health for Humanity, Creating a Better Future Together

No.33 Nanjing City Popularity Ranking No.7 Qixia District No.160 Jiangsu Pr No.1 Kang Zhong Liu Yao No.1 Chemistry Pharmaceuticals No.1 Yao Li Yan Jiu No.1 Generic Drugs No.2 Hao Materials No.2 Pharmaceutical APIs No.2 APIs No.2 Biotechnology Pharmaceuticals No.3 Innovative Drugs Products No.3 Yuan Yan Yao No.3 Antibodies No.3 Peptides 省级五一劳动奖 博士后工作站 中国专利优秀奖 高新技术企业 省级工程技术研究中心 省民营科技企业
More

Company Overview

  • Nature: Joint Venture Size: 1000-4999 employees Founded: 25年
  • Industry: Pharmaceuticals/Bioengineering 、 Raw Materials and Processing
  • Full name: Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd.。

Development Stage

  • Ranking: Ranked #33 in Nanjing City by popularity Ranked #1 in Nanjing Kang Zhong Liu Yao Company by popularity Ranked #1 in Nanjing Chemistry Pharmaceuticals Company by popularity Ranked #1 in Nanjing Yao Li Yan Jiu Company by popularity Ranked #1 in Nanjing Generic Drugs Company by popularity
  • Honors: 省级五一劳动奖 博士后工作站 According to algorithm
  • News: 2025-06-05:百奥赛图与南京正大天晴合作开发第二代全人IGF-1R抗体NTB003(BCG009)获中国临床试验许可。
  • Salary: 55.3% of positions earn 10-20K, In 2026 vs last yeargrew by 10%.。Master's salary: ¥25.6K, Doctorate salary: ¥29.3K.
  • R&D: "Medical & Health/Beauty & Healthcare" demand: 17.7%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 8.9%, "Computer/Network/Technology": 4.2%。
  • Recruiting: In 2026 vs 2025grew by 59%. Demand for highly educated talent: Master's: 108, Doctorate: 6.
  • Requirement: Education: 本科 leads with 46%. Experience: 1-3年 leads with 44.5%.
  • Region: Distributed across 52 regions, 南京: 35.4%, 广州: 2.4%, 济南: 1.9%, 重庆: 1.8%.

About the Company

[Summary] Health for Humanity, Creating a Better Future Together

Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. was established in 2001, jointly invested by Thailand's Chia Tai and Jiangsu Agricultural Reclamation. It has two wholly-owned subsidiaries: Jiangsu Purun Biomedical Co., Ltd. (API platform) and Nanjing Chia Tai Weikang Biomedical Co., Ltd. (commercial platform). The company covers the full industrial chain of "drug R&D, APIs, preparations, and sales," with products spanning therapeutic areas such as cardiovascular and cerebrovascular diseases, oncology, surgical perioperative care, gastroenterology, urology, and contrast imaging. It has been ranked among the top 100 Chinese chemical pharmaceutical companies for many consecutive years. R&D is the foundation, and innovation drives progress. The company adheres to the R&D philosophy of "driving innovation through generics, and driving the future through innovation," relying on R&D investment several times the industry average and a team of hundreds of expert-level researchers, its R&D strength has ranked among the national forefront. Currently, it obtains approval for 5-8 new products annually, with over 100 products under development, covering innovative drugs, sustained and controlled-release preparations, and featured generics. The continuous operation of the postdoctoral workstation also injects sustained innovative vitality into the company's development. Marketing accelerates competitiveness. Since operation, the company's average annual compound growth rate of sales has reached 33%, far exceeding the industry average. It has formed a tiered product portfolio supported by hundred-million-yuan product groups, featuring "chronic diseases in the elderly and anti-tumor" therapies, with equal emphasis on oral and injectable formulations. The professional academic promotion team exceeds 2,000 people, covering three major scenarios: "hospitals, pharmacies, and the internet." Combined with a three-level academic promotion system led by medical science and anchored by the marketing system, its core products have achieved market leadership in segments such as cardiovascular and cerebrovascular diseases, oncology, surgical perioperative care, and imaging. Strength builds glory and witness. After 20 years of development, the company's "dual-engine drive of R&D and marketing" continues to accelerate. With the expansion of the industrial chain upstream to APIs and downstream to comprehensive disease management, coupled with the deep integration of scientific management and intelligent manufacturing, the company's healthy, sustainable, and rapid development is promoted. It has successively received honors such as "National Torch Plan Key High-tech Enterprise," "National Excellent Enterprise for Scientific and Technological Innovation," "National Demonstration Enterprise for Drug Quality and Integrity Construction," "Jiangsu Province May Day Labor Award," and "Jiangsu Province Demonstration Enterprise for Integration of Informatization and Industrialization." Facing the future, it writes a new chapter. As the company's strategic goal of "One Center, Three Platforms" (i.e., building an intensive strategic headquarters and developing three platforms: R&D and innovation, preparation intelligent manufacturing, and API intelligent efficiency) is gradually realized, along with the successive operation of its two subsidiaries, Nanjing Chia Tai Tianqing's full industrial chain layout continues to improve. In the future, through sustained efforts in core areas, it will benefit more patients, thereby practicing the business tenet of "Health for Humanity, Creating a Better Future Together"!

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Nanjing Chia Tai Tianqing Recruitment Overview (381 open positions)

Manage
No.32
Company Recruitment Ranking in Nanjing City 򀀩
No.620
Recruitment Growth Ranking in Nanjing City 򀀩
No.3
Graduate Talent Ranking in Nanjing City 򀀩
No.2
Intern Talent Ranking in Nanjing City 򀀩

Nanjing Chia Tai Tianqing Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Up 354%
  • 2024: Down 61%
  • 2023: Down 3%
  • 2022: Up 89%
Nanjing Chia Tai Tianqing Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. growing? Nanjing Chia Tai TianqingMaster's recruitment over the years: 2025: 59 openings (up 354%), 2024: 13 openings (down 61%), 2023: 33 openings (down 3%), 2022: 34 openings (up 89%), 2021: 18 openings. Nanjing Chia Tai Tianqing master talent ranking in Nanjing: #3, Nanjing Chia Tai Tianqing master salary mostly around 20-50K.

Nanjing Chia Tai Tianqing Doctoral Degree Job Demand Analysis

(More)
+183%
Growth Rate
2026 vs 2025
Nanjing Chia Tai Tianqing Doctoral Hiring by Year: 2026 — 11 more jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
No.20
Doctoral Demand Ranking in Nanjing City 򀀩
¥20-50K
Doctoral Salary 򀀩
How fast is doctoral hiring at Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. growing? Nanjing Chia Tai TianqingDoctorate recruitment over the years: 2026: 17 openings (up 222%), 2025: 6 openings (up 354%), 2023: 6 openings (down 3%), 2022: 2 openings (up 89%). Nanjing Chia Tai Tianqing doctorate talent ranking in Nanjing: #20, Nanjing Chia Tai Tianqing doctorate salary mostly around 20-50K.

Nanjing Chia Tai Tianqing R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd.? Based on an analysis of Nanjing Chia Tai Tianqing's job postings over the past year, "Medical & Health/Beauty & Healthcare" demand: 17.7%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 8.9%, "Computer/Network/Technology": 4.2%, "Other (R&D and Technical)": 3.3%, "Scientific Research": 2.9%, "Electrical/Energy/Power": 1.2%. For reference only.

Nanjing Chia Tai Tianqing — What Are the Salaries Like? (1119 records)

Manage
Nanjing Chia Tai Tianqing Salary Overview
salary range: 3K - 50K, 55.3% of roles pay ¥10-20K
Note: salary statistics are based on 1119 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd.?Nanjing Chia Tai Tianqing55.3% of positions earn 10-20K, Fresh graduate salary: ¥11.1K。Nanjing salary ranking top 25,销售类 average salary ¥15.3K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Nanjing Chia Tai Tianqing

(More)
Are salaries high at Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd.? We provide: Pharmaceutical Sales Representative, Promotion Specialist, Academic Specialist, 临床, Medical Manager, Sales, Intern, Channel Manager, Key Account Manager, Product Manager, QC, Distribution Specialist, Pharmacy, Account Manager, Researcher, 药学, RA, BP, Medical Advisor, Information. Click to view detailed salary analysis by job.

Job Category

  • 销售类
    63% of total 63%
  • 医疗卫生/美容保健类
    19% of total 19%
  • 生物/制药/化工/环保类
    10.5% of total 10.5%
  • 市场/公关/媒介类
    9.8% of total 9.8%

Education

  • 本科
    46% of total 46%
  • 大专
    32.5% of total 32.5%
  • 硕士
    18% of total 18%
  • 不限
    1.9% of total 1.9%

Experience

  • 1-3年
    44.5% of total 44.5%
  • 不限
    20.5% of total 20.5%
  • 3-5年
    19.3% of total 19.3%
  • 应届生
    8.1% of total 8.1%
View Detailed Analysis

What does Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. require? Who is Nanjing Chia Tai Tianqing hiring? Nanjing Chia Tai Tianqing recruitment: 销售类占比最多占63%,其次是医疗卫生/美容保健类占19%. What education can get in at Nanjing Chia Tai Tianqing? 本科占比最多占46%,其次是大专占32.5%. High education required at Nanjing Chia Tai Tianqing? 硕士占18%,博士占1.6%. Work experience required at Nanjing Chia Tai Tianqing? 1-3年占比最多占44.5%,其次是不限占20.5%. Where are the job locations at Nanjing Chia Tai Tianqing? 南京占比最多占35.4%,其次是广州占2.4%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 33,603.1726万(元)
Legal Representative: 谢炳
Date Established:
Credit Code: 91320100730586189T
Registered Address: 南京经济技术开发区惠欧路9号

Partners & Suppliers

区域性药品分销及委托配送 Source
合作客户 商业分销
通过国控分销网络销售药品 Source
合作客户 商业分销
提供化学药及生物药的合同研发生产服务 Source
供应商 合同研发生产(CDMO)
柯菲平委托其进行药品生产 Source
合作客户 委托生产(CMO)
药品批发及零售渠道合作 Source
合作客户 商业分销

People who follow Nanjing Chia Tai Tianqing also follow

Nanjing Chia Tai Tianqing Competitors (Similar Companies)

“A renowned enterprise in China's liver disease and anti-tumor fields”
“Manufacturing "biochips" to provide source power for the development o”
“Research, development, and production of anti-tumor and surgical medic”
“Helping patients access more effective medicines sooner”
生物科技/生物工程 医药 基因合成 生物医药
“Innovative chemical products and services provider in the drug researc”
“It is an innovation-driven pharmaceutical group integrating drug resea”
软膏剂 医药工业 原料药 制药/药业
“Seek and strive, protect and heal all beings”
通信工程监理 造价咨询 工程监理 通信工程
直发器 洁面仪 卷发器 吹风机
速冻食品 火锅料制品 生产 火锅
工程咨询 工程设计 环境评价/环评 工程勘察
“Continuously innovating to bring patients medicines that significantly”
“Building a first-class engineering group company in the industry”

Discover Great Companies, Discover Great Clients

南京公司名录 南京“Qixia District”公司名录 南京“制药/药业”公司名录 南京“生物制药”公司名录 南京“化学制药”公司名录 南京“仿制药”公司名录 南京“原料药”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates